130 results match your criteria: "Hospital General de Elche[Affiliation]"
PLoS One
February 2017
Infectious Diseases Unit, Hospital General de Elche, Universidad Miguel Hernández, Alicante, Spain.
Objective: We aimed to assess whether oxidative stress is a predictor of mortality in HIV-infected patients.
Methods: We conducted a nested case-control study in CoRIS, a contemporary, multicentre cohort of HIV-infected patients, antiretroviral-naïve at entry, launched in 2004. Cases were patients who died with available stored plasma samples collected.
Arch Bronconeumol
October 2016
Sección de Neumología, Hospital General de Elche, Elche, Alicante, España.
Medicine (Baltimore)
March 2016
From the Infectious Diseases Unit, Hospital General de Elche (MM, SP, GT, FL, FG), Universidad Miguel Hernández, Spain; and Statistics (XB, MS), Centro de Investigación Operativa, Universidad Miguel Hernández, Elche, Alicante, Spain.
Although different factors have been implicated in the CD4/CD8 T-cell ratio recovery in HIV-infected patients who receive effective antiretroviral therapy (ART), limited information exists on the influence of the regimen composition. A longitudinal study carried out in a prospective, single-center cohort of HIV-infected patients. ART regimens including non-nucleoside reverse transcriptase inhibitors (NNRTI), protease inhibitors (PI), or integrase strand transfer inhibitors (INSTI) from patients who achieved long-term (≥6-month duration) virological suppression (HIV-RNA < 400 copies/mL) from January 1998 to June 2014 were analyzed.
View Article and Find Full Text PDFClin Infect Dis
May 2016
Laboratory of Immunovirology, Clinic Unit of Infectious Diseases, Microbiology and Preventive Medicine, Institute of Biomedicine of Seville, Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital.
Background: Human immunodeficiency virus (HIV) controllers have the striking ability to maintain viremia at extremely low or undetectable levels without antiretroviral treatment. Even though these patients have been widely studied, information about clinical outcomes, especially concerning to non-AIDS-defining events (nADEs), is scarce. We have analyzed the frequency and rate of nADEs and their associated factors in a large multicenter HIV controller cohort.
View Article and Find Full Text PDFObjectives: Chronic oxidative stress (OS) may play a role in cardiovascular disease in HIV-infected patients, and increased bilirubin levels may have a beneficial role in counteracting OS. Atazanavir (ATV) inhibits UDP-glucuronosyl-transferase 1A1 (UGT1A1), thus increasing unconjugated bilirubin levels. We aimed to compare changes in OS markers in patients on ATV/ritonavir (ATV/r)- vs.
View Article and Find Full Text PDFAddiction
July 2016
Centro Nacional de Epidemiología, Instituto de Salud Carlos III, Madrid, Spain.
Aims: To compare patients who acquired HIV infection through use of injected drugs (HIV-IDU) with patients who acquired HIV by sexual transmission (HIV-ST) in terms of late presentation (LP), delay in anti-retroviral treatment (ART) initiation, virological and immunological response to ART, mortality and progression to AIDS.
Design: Prospective multi-centre cohort study of HIV-infected subjects naive to ART at entry (Cohort of the Spanish HIV Research Network: CoRIS).
Setting: Thirty-one centres from the Spanish public health-care system.
Rev Calid Asist
March 2018
Universidad Miguel Hernández, Elche, Alicante, España; Atención Primaria, Departamento de Salud Alicante-Sant Joan, Sant Joan d'Alacant, Alicante, España.
Objective: To determine and update the skills map for the position of Nurse Administrator in hospitals and Primary Care.
Method: An observational, descriptive, cross-sectional study based on a Delphi technique was conducted in hospital and Primary Care settings. Two nominal groups with 15 nurses each were used to define the contents of the questionnaire 0 in the Delphi technique.
J Clin Oncol
November 2015
Miguel Martín, Instituto de Investigación Sanitaria Gregorio Marañón, Universidad Complutense; Carlos Jara, Fundación Hospitalaria de Alcorcón; Noelia Martínez-Jáñez, Hospital Universitario Ramón y Cajal; César Mendiola Fernández, Hospital Universitario; Ana Isabel Ballesteros, Hospital de la Princesa; Maribel Casas, María del Carmen Cámara, and Eva Carrasco, GEICAM Headquarters, Madrid; Amparo Ruiz Simón, Instituto Valenciano de Oncología; Ana Santaballa, Hospital Universitario La Fe; Ana Lluch, Hospital Clínico Universitario de Valencia-INCLIVA-Universidad de Valencia, Valencia; Manuel Ruiz Borrego, Hospital Universitario Virgen del Rocío, Sevilla; Nuria Ribelles, Hospital Universitario Virgen de la Victoria IBIMA, Málaga; Álvaro Rodríguez-Lescure, Hospital General de Elche; Encarna Adrover, Hospital Clínico Universitario de Alicante, Alicante; Montserrat Muñoz-Mateu, Hospital Clinic i Provincial; Sonia González, Hospital Mutua de Terrassa; Mireia Margelí Vila, Hospital Universitario Germans Trias i Pujol; Agustí Barnadas, Universitat Autònoma de Barcelona, Barcelona; Manuel Ramos, Centro Oncológico de Galicia; Lourdes Calvo, Complejo Hospitalario Universitario A Coruña, A Coruã; Sonia Del Barco Berron, Instituto Catalán de Oncología, Girona; César A. Rodríguez, Hospital Universitario de Salamanca, Salamanca, Spain; Eduardo Martínez de Dueñas, Hospital Provincial de Castellón, Castellón; Raquel Andrés, Hospital Universitario Lozano Blesa, Zaragoza; Arrate Plazaola, Onkologikoa, San Sebastián; Juan de la Haba-Rodríguez, Universidad de Córdoba, Córdoba; Jose Manuel López-Vega, Hospital Universitario Marqués de Valdecilla, Santander; Pedro Sánchez-Rovira, Complejo Hospitalario de Jaén, Jaén; and José M. Baena-Cañada, Hospital Universitario Puerta del Mar, Cádiz, Spain.
Purpose: Capecitabine is an active drug in metastatic breast cancer (BC). GEICAM/2003-10 is an adjuvant trial to investigate the integration of capecitabine into a regimen of epirubicin and docetaxel for node-positive early BC.
Patients And Methods: Patients with operable node-positive BC (T1-3/N1-3) were eligible.
Fam Cancer
December 2015
Laboratory of Molecular Biology, Service of Clinical Analysis, University and Polytechnic Hospital La Fe, Escuela de Enfermería 7ª planta. Avd. Campanar 21, Valencia, 46009, Spain.
J Clin Microbiol
February 2015
Infectious Diseases Unit, Hospital General de Elche, Universidad Miguel Hernández, Alicante, Spain.
Spiroplasma species are organisms that normally colonize plants and insects. We describe the first case of human systemic infection caused by Spiroplasma bacteria in a patient with hypogammaglobulinemia undergoing treatment with biological disease-modifying antirheumatic agents. Spiroplasma turonicum was identified through molecular methods in several blood cultures.
View Article and Find Full Text PDFClin Infect Dis
December 2014
Janssen Infectious Diseases BVBA.
Background: Simeprevir is an oral, once-daily, hepatitis C virus (HCV) NS3/4A protease inhibitor for the treatment of chronic HCV genotype 1 infection. Human immunodeficiency virus (HIV) coinfection accelerates progression of liver disease. This uncontrolled, open-label trial explored the safety and efficacy of simeprevir in patients with HCV genotype 1/HIV type 1 (HIV-1) coinfection.
View Article and Find Full Text PDFBr J Cancer
October 2014
Department of Medical Oncology and Department of Pathology, Hospital Universitario Virgen de la Victoria, 29010 Malaga, Spain.
Background: In this study, we evaluated the ability of gene expression profiles to predict chemotherapy response and survival in triple-negative breast cancer (TNBC).
Methods: Gene expression and clinical-pathological data were evaluated in five independent cohorts, including three randomised clinical trials for a total of 1055 patients with TNBC, basal-like disease (BLBC) or both. Previously defined intrinsic molecular subtype and a proliferation signature were determined and tested.
Rev Esp Cardiol (Engl Ed)
September 2013
Unidad de Hemodinámica, Sección de Cardiología, Hospital General de Elche, Elche, Alicante, Spain.
Introduction And Objectives: Intracoronary ultrasound estimation of the functional significance of intermediate angiographic lesions has mainly been based on measuring the minimal lumen area. These estimates take no account of lesion length and pay insufficient attention to long coronary lesions.
Methods: We included 61 lesions with visual angiographic stenosis of 40% to 70% that required treatment with a ≥20mm stent, studied with ultrasound and fractional flow reserve.
Transl Res
December 2014
Department of Hematology, Hospital de Guadalajara, c/Donantes de sangre s/n, Guadalajara 19002, Spain. Electronic address:
Dissemination of neoplastic cells into the cerebrospinal fluid (CSF) and leptomeninges is a devastating complication in patients with epithelial cell neoplasia (leptomeningeal carcinomatosis [LC]) and lymphomas (lymphomatous meningitis [LyM]). Information about the surrounding inflammatory cell populations is scarce. In this study, flow cytometry immunophenotyping was used to describe the distribution of the main leukocyte populations in the CSF of 83 patients diagnosed with neoplastic meningitis (LC, n = 65; LyM, n = 18).
View Article and Find Full Text PDFSaudi J Kidney Dis Transpl
January 2014
Nephrology Section, Hospital General de Elche, Alicante, Spain.
Metamizole or dipyrone is a pyrazolone derivative that belongs to the non-steroidal anti-inflammatory drugs. Its main side-effect is hematological toxicity. Thrombocytopenia due to metamizole is rare and is usually associated with the involvement of the two other blood series.
View Article and Find Full Text PDFN Engl J Med
November 2013
From the University Health Network, Toronto (S.L.W.); Hospital Clinico Universitario, Santiago de Compostela (A.A.), and Hospital General de Elche and Universidad Miguel Hernández, Alicante (F.G.) - both in Spain; Centre Hospitalier Universitaire Saint-Pierre, Brussels (N.C.); Dr. Victor Babes Infectious and Tropical Diseases Hospital, Bucharest, Romania (D.D.); Medizinisches Versorgungszentrum Karlsplatz HIV Research and Clinical Care Center, Munich, Germany (A.E.); Centre Hospitalier Régional d'Orléans, Orléans, France (L.H.); Antiviral Therapy Unit, Ospedali Riuniti, Bergamo, Italy (F.M.); University of Nebraska Medical Center, Omaha (U.S.); GlaxoSmithKline, Stockley Park, United Kingdom (C.G.); and GlaxoSmithKline, Research Triangle Park, NC (K.P., B.W., S.M., G.N.).
Background: Dolutegravir (S/GSK1349572), a once-daily, unboosted integrase inhibitor, was recently approved in the United States for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in combination with other antiretroviral agents. Dolutegravir, in combination with abacavir-lamivudine, may provide a simplified regimen.
Methods: We conducted a randomized, double-blind, phase 3 study involving adult participants who had not received previous therapy for HIV-1 infection and who had an HIV-1 RNA level of 1000 copies per milliliter or more.
Ren Fail
February 2014
Nephrology Section, Hospital General de Elche, Elche, Spain.
Cryopyrin-associated periodic syndrome (CAPS) is due to gain-of-function mutations in the cryopyrin gene, which determines an overactive inflammatory response. AA amyloidosis is a complication of this syndrome. A 53-year-old man was referred to us because of lower limb edema.
View Article and Find Full Text PDFInt Urol Nephrol
December 2010
Nephrology Section, Hospital General de Elche, Camí de L'Almazara, 03203 ELCHE, Alicante, Spain.
A 45-year-old woman presented with phenotypical features suggestive of Gitelman syndrome (adult age at diagnosis, normal-low blood pressure, hypokalaemia, metabolic alkalosis, hypomagnesaemia, and hypocalciuria). Mutational analysis revealed no significant abnormality in SLC12A3 gene, but homozygous p.A204T mutation was found in the CLCNKB gene.
View Article and Find Full Text PDFRen Fail
May 2010
Nephrology Section, Hospital General de Elche, 03203 Elche, Spain.
Hepatitis B virus (HBV) infection is an uncommon cause of cryoglobulinemia. Renal cryoglobulinemia has been rarely reported in the setting of chronic hepatitis B infection. We describe a case of chronic hepatitis B infection with cryoglobulinemic glomerulonephritis (Gn) and provide information about the treatment and the evolution over a 30-month follow-up.
View Article and Find Full Text PDFArch Esp Urol
December 2009
Servicio de Oncología Radioterápica, ERESA, Hospital General de Elche, 03203 Elche, Alicante, España.
External beam radiotherapy is consolidated like radical treatment for localized and locally advanced prostate cancer. In addition, more and more studies show its effectiveness as much in postoperative as in salvage intention. Before choosing a therapeutic option, it is important to know the baseline state of the patients and the possible side effects of the treatment.
View Article and Find Full Text PDFArch Esp Urol
December 2009
Unidad de Urodinámica, Servicio de Urología, Hospital General de Elche, 03230 Elche, España. Prieto
Objectives: Prostate cancer is the urologic neoplasia that has experienced more changes in the last decade, with a great increase in incidence and diagnosis. Prostate cancer patient's management is clearly multidisciplinary, with the participation of urologists mainly, but also specialized pathologists, radiologists, biochemists, medical oncologists, radiation oncologists and others. The expected long survival makes the routine visit for PSA control non sustainable, without paying attention to the presence of urinary symptoms and other functional disorders with great repercussion on the quality of life.
View Article and Find Full Text PDFRev Esp Cardiol
March 2009
Sección de Cardiología, Hospital General de Elche, Elche, 03007 Alicante, Spain.
We studied 3162 heart failure patients included in the Spanish BADAPIC registry in order to determine whether statin treatment influences prognosis. Patients were followed up for 35 +/- 22 months (median, 32 months). Patients on statins were more often male and had higher prevalences of risk factors, ischemic heart disease and systolic dysfunction (P< .
View Article and Find Full Text PDFClin Nephrol
February 2009
Nephrology Section, Hospital General de Elche, Spain.
A 41-year-old man with Type 2 diabetes developed sudden onset of nephrotic syndrome. He initially refused a renal biopsy. However, 3 months later, the nephrotic syndrome persisted and percutaneous renal biopsy was performed.
View Article and Find Full Text PDFJ Nephrol
September 2008
Nephrology Section, Hospital General de Elche, Elche - Spain.
A 56-year-old man presented with peripheral monocytosis and massive nephrotic syndrome. He was diagnosed as having chronic myelomonocytic leukemia and membranous glomerulonephritis. He received prednisone, chlorambucil and hydroxyurea, but the nephrotic syndrome persisted.
View Article and Find Full Text PDFScand J Urol Nephrol
May 2008
Nephrology Section, Hospital General de Elche, Elche, Spain.
Objective: To study the prevalence of hepatitis B and C viruses in patients with glomerulonephritis (Gn). Material and methods. This was a retrospective study of 89 patients (36 females, 53 males) diagnosed with Gn.
View Article and Find Full Text PDF